对手 发表于 2025-3-26 22:09:59

http://reply.papertrans.cn/2/185/18439/18439-31.png

inundate 发表于 2025-3-27 02:27:05

http://reply.papertrans.cn/2/185/18439/18439-32.png

corpus-callosum 发表于 2025-3-27 06:01:24

Submitted on: 17 July 2000.
Revised on: 02 September 2000.
Accepted on: 02 October 2000.

___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Cpr951 发表于 2025-3-27 12:20:23

http://reply.papertrans.cn/2/185/18439/18439-34.png

AMPLE 发表于 2025-3-27 14:44:48

Submitted on: 07 June 2018.
Revised on: 16 August 2018.
Accepted on: 06 October 2018.

___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

圣人 发表于 2025-3-27 17:53:38

http://reply.papertrans.cn/2/185/18439/18439-36.png
页: 1 2 3 [4]
查看完整版本: SCIE期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS 2024/2025影响因子:1.963 (J OCUL PHARMACOL TH) (1080-7683). (OPHTHALMO